# Will AI PBM Compliance Monitoring Become a Fiduciary Necessity by 2026?

Lily Armstrong · October 28, 2026

> Rising Pressure on PBM Transparency As federal and state scrutiny of pharmacy benefit managers intensifies, self-funded employers are facing a new...

## Rising Pressure on PBM Transparency

As federal and state scrutiny of pharmacy benefit managers intensifies, self-funded employers are facing a new reality: their ERISA fiduciary duties now require more than just reviewing an annual PBM report. With the FTC launching its healthcare task force, expanding its investigation into inhaler pricing, and a wave of PBM-focused legislation gaining momentum, plan sponsors can no longer take their PBM's word at face value. The burden of proof is shifting, and blindly accepting rebate guarantees or spread pricing is becoming increasingly difficult to justify to regulators and members alike.

**Also worth reading:** [How Can an AI Healthcare Benefits Consultant Build a PBM Audit Compliance Checklist?](https://healtho.io/knowledge/how_can_an_ai_healthcare_benefits_consultant_build_a_pbm_audit_compliance_checklist.php) · [How Can Medicare Advantage AI Audit Readiness Strengthen Compliance?](https://healtho.io/knowledge/how_can_medicare_advantage_ai_audit_readiness_strengthen_compliance.php) · [What Critical Steps Must Healthcare Providers Take For AI Vendor HIPAA Compliance Vetting Before Signing A Contract?](https://healtho.io/knowledge/what_critical_steps_must_healthcare_providers_take_for_ai_vendor_hipaa_compliance_vetting_before_signing_a_contract.php)

With enforcement risk rising, AI-powered PBM compliance monitoring is quickly moving from a competitive advantage to a fiduciary necessity by 2026. Platforms like Milliman SkySail are already enabling real-time comparisons between actual claims and contracted terms to flag hidden fees before they compound. As more plan sponsors adopt these tools to demonstrate prudence, failing to do so may soon be viewed as imprudent itself. For those tasked with protecting plan assets, automated oversight may soon be the minimum expected standard of care.

## How AI Flags Hidden PBM Fees

As self-funded employers shoulder more of their pharmacy spend, AI PBM compliance monitoring is quickly shifting from a cost-cutting tool to a matter of legal duty. With the FTC expanding its scrutiny of spread pricing, rebate retention, and other opaque practices, plan fiduciaries are being pushed to prove they are actively policing their PBM contracts. Machine learning can now scan millions of claims to flag hidden fees, inflated dispensing costs, or deviations from guaranteed rates in near real time. For many, this level of oversight is the only realistic way to verify what is actually being paid versus what was promised.

By 2026, the convergence of ERISA obligations, new state transparency laws, and rising federal enforcement may make this technology a fiduciary necessity. Solutions like Milliman SkySail are already gaining traction among benefits advisors who know that "trust but verify" is no longer defensible. Without automated compliance checks, fiduciaries risk falling short of their duty of prudence. As litigation against PBMs mounts, failing to use AI to validate pharmacy spend could soon be viewed not as a missed opportunity, but as a breach of duty.

## Mapping AI to Evolving PBM Laws

The pharmacy benefit management industry is facing unprecedented regulatory scrutiny, and artificial intelligence is emerging as the mechanism through which compliance may actually become enforceable. With the FTC's investigations into insulin pricing and inhaler patent practices, alongside state legislation demanding transparency in rebate flows and spread pricing, PBMs are being asked to document decisions in ways manual processes cannot sustain. Tools like Milliman SkySail, recently adopted by 90 Degree Benefits, signal a shift toward AI-driven optimization that can simultaneously track pricing integrity, rebate pass-through, and formulary rationale. For plan sponsors and consultants like healtho.io, this creates a new standard: if technology exists to monitor PBM conduct continuously, failing to use it may look like negligence.

By 2026, the question shifts from whether AI compliance monitoring is useful to whether fiduciary duty requires it. ERISA fiduciaries are already expected to benchmark fees and disclose conflicts in retirement plans; health benefits are following the same trajectory. Regulators, courts, and plaintiffs' attorneys will increasingly ask why a fiduciary lacked real-time visibility into PBM performance when affordable AI tools existed. Early adopters won't just reduce costs—they'll build the documented diligence record that defends their decisions.

## FTC Scrutiny Driving Adoption

The Federal Trade Commission's growing crackdown on pharmacy benefit managers is raising the stakes for self-funded plan fiduciaries. With its healthcare task force, ongoing probes into inflated drug prices like inhalers, and a wave of new PBM legislation, regulators are making one thing clear: passive oversight is no longer defensible under ERISA's duty of prudence. Traditional annual audits simply cannot keep pace with complex rebate structures, spread pricing, and mid-year formulary changes. AI-powered PBM compliance monitoring offers a way to continuously compare claims activity against contracted terms, flagging potential breaches in near real-time before they become costly or expose plans to legal risk.

As the PBM industry itself leans into AI to optimize operations, the gap between what PBMs can analyze and what plan sponsors can verify is shrinking in the wrong direction. With enforcement actions accelerating and the standard of care evolving, demonstrating active, data-driven oversight is likely to become expected by 2026. For many self-funded employers, AI PBM compliance monitoring won't just be a smart cost-control measure, but a fiduciary necessity to prove they are meeting their obligations in an increasingly hostile regulatory climate.

## Pragmatic Steps for Benefits Teams

As ERISA fiduciaries, employer plan sponsors are facing a new level of accountability for their pharmacy spend. With the FTC launching its healthcare task force and expanding its investigation into PBM practices, regulatory heat is rising alongside bipartisan calls for reform. Moves like 90 Degree Benefits selecting Milliman SkySail show that AI-driven PBM oversight is already moving from pilot to practice. For benefits teams, the duty of prudence now demands more than reviewing a summary report once a year. The ability to flag spread pricing, rebate shortfalls, or formulary changes in near real-time is quickly becoming the bare minimum to demonstrate active oversight.

At the same time, PBMs themselves are racing to deploy AI to protect their own margins, making manual audits far too slow to keep pace. With growing litigation risk and state-level crackdowns, experts expect courts and regulators to judge fiduciary action by what was reasonably knowable at the time. While no explicit mandate exists yet, the convergence of enforcement and technology strongly points to AI PBM compliance monitoring becoming a fiduciary necessity by 2026. For plan sponsors, waiting for a rule may be far riskier than acting now.

## AI vs Manual PBM Compliance Audits

| Dimension | Manual PBM Audits | AI-Powered Monitoring |
| --- | --- | --- |
| Claims review speed | Weeks to months per audit cycle | Real-time, continuous transaction screening |
| Error detection | Sample-based, often missing 10–20% of discrepancies | Flagging of pricing spreads, ghost networks, and rebate mismatches at scale |
| Regulatory alignment | Reactive updates after state or FTC actions | Automated tracking of evolving PBM transparency laws |
| Fiduciary documentation | Static reports, prone to gaps | Audit-ready logs supporting ERISA duty-of-prudence evidence |

As regulators intensify scrutiny of pharmacy benefit managers, plan sponsors face mounting pressure to demonstrate prudent oversight of their PBM contracts. AI-driven compliance monitoring offers continuous claims validation, rebate reconciliation, and pricing transparency checks that manual audits cannot match. By 2026, fiduciaries may find that failing to deploy such tools leaves them exposed to legal and reputational risk.

## Quick answers

### What is AI PBM compliance monitoring?

It uses AI to scan PBM claims, rebates, and fees to detect potential violations of state and federal rules.

### Who benefits most from this approach?

Self-insured employers, TPAs, and AI healthcare benefits consultants looking to meet their growing fiduciary duties.

### Can AI detect spread pricing violations?

Yes, anomaly detection models can flag unusual markups by comparing PBM charges to real acquisition costs.

### How does this help with FTC scrutiny?

It creates time-stamped, auditable logs that prove proactive oversight of PBM practices.

Canonical: https://healtho.io/knowledge/will_ai_pbm_compliance_monitoring_become_a_fiduciary_necessity_by_2026.php
Markdown: https://healtho.io/knowledge/will_ai_pbm_compliance_monitoring_become_a_fiduciary_necessity_by_2026.php/index.md